The Next Ambien?

“Is a sleeper hit on the way for insomnia treatments? “ (Forbes) Takeda Pharmaceuticals just announced FDA approval for the US marketing of Rozerem, the brand name for remelteon, a sleep agent that works by a completely novel mechanism, unlike all of the agents in use these days, which are variations on the GABA theme. Rozerem is also going to be the first sleeping pill which is not a scheduled (controlled) drug, indicating the FDA’s assessment that it has no abuse or addictive potential. I will reserve judgment until I read some of the scientific papers and until I have seen it in action…